Kjane J. Escott
BioPharmaceuticals R&D, AstraZeneca
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trial.
Journal: Arthritis research & therapy
Published: April 07, 2022
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough.
Journal: ERJ open research
Published: September 08, 2021
An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone pain.
Journal: Journal of bone oncology
Published: August 13, 2019
Drug repurposing: progress, challenges and recommendations.
Journal: Nature reviews. Drug discovery
Published: October 13, 2018
GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
Journal: Journal of cellular physiology
Published: March 29, 2017
Effects of Src-kinase inhibition in cancer-induced bone pain.
Journal: Molecular pain
Published: January 22, 2016
Pioneering government-sponsored drug repositioning collaborations: progress and learning.
Journal: Nature reviews. Drug discovery
Published: November 21, 2015
Preclinical toxicity of AZD7969: Effects of GSK3β inhibition in adult stem cells.
Journal: Toxicologic pathology
Published: October 19, 2014
Human stem cell osteoblastogenesis mediated by novel glycogen synthase kinase 3 inhibitors induces bone formation and a unique bone turnover biomarker profile in rats.
Journal: Toxicology and applied pharmacology
Published: April 24, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026